INSIDER · CIK 1366074
Lappe Mark
Chief Executive Officer, Director at Inhibrx Biosciences, Inc. (INBX)
↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$4.5MBought on the market
$0.00Sold on the market
1Companies
Oct 14, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 202618:58 | Oct 14, 2026 | INBXInhibrx Biosciences, Inc. | Chief Executive Officer, Director | P · Buy | $84.56 | +10,040 | 170,000 | +6% | +$849K | -33.3% | -12.9% |
| Sep 28, 202617:47 | Sep 28, 2026from Sep 25, 2026 | INBXInhibrx Biosciences, Inc. | Chief Executive Officer, Director | P · Buy | $99.88 | +10,000 | 740,548 | +1% | +$999K | -21.2% | -26.3% |
| Sep 8, 202616:04 | Sep 8, 2026 | INBXInhibrx Biosciences, Inc. | Chief Executive Officer, Director | P · Buy | $105.82 | +25,000 | 730,548 | +4% | +$2.6M | -16.5% | -30.4% |